C. Mitoma
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
-
- Metabolism and Genetic Disorders 5
- Co-authors
- Sidney Udenfriend (2 shared papers)Bernard B. Brodie (1 shared paper)Leo E. Gaudette (1 shared paper)Bert N. La Du (1 shared paper)Jack R. Cooper (1 shared paper)Julius Axelrod (1 shared paper)Masato Tanabe (2 shared papers)Gordon T. Pryor (2 shared papers)
- Journals
- Experimental Biology and Medicine (3 papers)Drug and Chemical Toxicology (2 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (2 papers)Xenobiotica (2 papers)Pharmacology Biochemistry and Behavior (1 paper)
- Partner nations
- United StatesSouth Korea
In The Last Decade
C. Mitoma
18 papers receiving 373 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 109
- Clinical Biochemistry 71
- Biochemistry 44
- Pharmaceutical Science 23
- Cancer Research 46
Countries citing papers authored by C. Mitoma
This map shows the geographic impact of C. Mitoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mitoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mitoma more than expected).
Fields of papers citing papers by C. Mitoma
This network shows the impact of papers produced by C. Mitoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mitoma. The network helps show where C. Mitoma may publish in the future.
Co-authors
The 22 scholars most cited alongside C. Mitoma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1955 | 174 | |
| 2 | 1957 | 67 | |
| 3 | 1967 | 32 | |
| 4 | 1985 | 31 | |
| 5 | 1978 | 18 | |
| 6 | 1970 | 17 | |
| 7 | 1971 | 15 | |
| 8 | 1977 | 14 | |
| 9 | 1983 | 11 | |
| 10 | 1977 | 10 | |
| 11 | Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats. | 1997 | 8 |
| 12 | 1967 | 7 | |
| 13 | 1983 | 6 | |
| 14 | 1973 | 4 | |
| 15 | 1983 | 3 | |
| 16 | 1973 | 3 | |
| 17 | 1977 | 2 | |
| 18 | Response to drugs by rats showing long or short hexobarbital-induced sleep. | 1970 | 1 |
About C. Mitoma
C. Mitoma is a scholar working on Clinical Biochemistry, Molecular Biology, Biochemistry, Pharmacology and Pharmaceutical Science, having authored 18 papers that have together received 423 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Chemical Reactions and Isotopes (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Sulfur Compounds in Biology (2 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmacology (109 citations), Clinical Biochemistry (71 citations), Biochemistry (44 citations), Pharmaceutical Science (23 citations) and Cancer Research (46 citations). C. Mitoma has collaborated with scholars based in United States and South Korea. Frequent co-authors include Sidney Udenfriend, Bernard B. Brodie, Leo E. Gaudette, Bert N. La Du, Jack R. Cooper, Julius Axelrod, Masato Tanabe, Gordon T. Pryor, Dennis Yasuda and David W. Thomas. Their work appears in journals such as Experimental Biology and Medicine, Drug and Chemical Toxicology, Biochimica et Biophysica Acta (BBA) - General Subjects, Xenobiotica and Pharmacology Biochemistry and Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.